期刊文献+

P364L突变降低UGT1A1酶对非结合胆红素的催化活性 被引量:1

Mutant P364L reduces catalytic activity of UDP-glucuronosyltransferase 1A1 on unconjugated bilirubin in vitro
下载PDF
导出
摘要 目的研究尿苷二磷酸葡萄糖醛酸基转移酶1A1的P364L突变型(c.1091 C>T)对催化非结合胆红素葡糖醛酸化的影响。方法构建含有UGT1A1编码序列的野生型和P364L突变型质粒,转染HEK293细胞,表达野生型与突变型蛋白;Western blot验证野生型和P364L突变型蛋白表达情况;超声裂解细胞提取表达蛋白;设计两组反应,野生型为对照组,P364L突变型为实验组,分别催化非结合胆红素反应,HPLC定量检测两组中非结合胆红素浓度变化情况。结果对照组中非结合胆红素的浓度随着时间的延长呈逐渐下降的趋势,而结合胆红素的浓度随时间延长逐渐升高;实验组中非结合胆红素浓度下降程度远小于对照组,未见明显的结合胆红素峰值;反应30 min时计算酶的活性P364L突变型为野生型的14.2%。结论突变酶UGT1A1-P364L催化非结合胆红素能力较野生型明显降低。 Objective To investigate the effect of UDP-glucuronosyhransferase 1A1 ( UGT1A1 ) genetic mutant P364L (c. 1091 C 〉 T) on the glucuronidation of unconjugated bilirubin. Methods The UGT1A1 wild-type and mutant P364L gene sequences were inserted into plasmid pEZ-M03 respectively, and then transfected into HEK293 cells. Western blotting was applied to test the expression of wild-type and mutant P364L-UGT1A1 proteins. Ultrasound was used to extract the intra-cellular compounds. High- performance liquid chromatography (HPLC) was used to detect the level of unconjugated bilirubin in both wild-type and mutant P364L catalytic reaction. Results The concentration of unconjugated bilirubin was significantly decreased while the peak concentration of conjugated bilirubin was increased over time in wild- type UGT1AI catalytic reaction. However, the concentration of unconjugated bilirubin was slightly decreased over time and the peak concentration of conjugated bilirubin was not obviously detected in P364L-UGT1A1 catalytic reaction. The mutant P364L-UGT1A1 contained only 14. 2% of wild-type enzyme activity. Conclusion Mutant P364L-UGT1A1 (1091C 〉 T) has significantly lower enzyme activity to catalyze unconjugated bi]irubin than wild-type UGT1A1.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2015年第10期1017-1021,共5页 Journal of Third Military Medical University
关键词 尿苷二磷酸葡糖醛酸基转移酶1A1 胆红素 葡糖醛酸化 突变体 UDP-glucuronosyltransferasel A1 bilirubin glucuronidation mutation
  • 相关文献

参考文献11

  • 1Tukey R H, Strassburg C P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease[J]. Annu Rev Pharmacol Toxicol, 2000, 40: 581-616. 被引量:1
  • 2Takeuchi K, Kobayashi Y, Tamaki S, et al. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert’s syndrome as well as in healthy Japanese subjects[J]. J Gastroenterol Hepatol, 2004, 19(9): 1023-1028. 被引量:1
  • 3Mimura Y, Maruo Y, Ohta Y, et al. Effect of common exon variant (p.P364L) on drug glucuronidation by the human UDP-glucuronosyltransferase 1 family[J]. Basic Clin Pharmacol Toxicol, 2011, 109(6): 486-493. 被引量:1
  • 4李露锋,邓国宏,谭文婷,郭鑫武,但芸婕,李艳华,唐怡,毛青.8个Gilbert综合征家系UGT1A1变异谱调查及分析[J].第三军医大学学报,2014,36(23):2408-2412. 被引量:3
  • 5Lee S J, Park J B, Kim D, et al. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug drug interactions[J]. Toxicol Lett, 2015, 232(2): 458-465. 被引量:1
  • 6Korprasertthaworn P, Rowland A, Lewis B C, et al. Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivity[J]. Biochem Pharmacol, 2012, 84(11): 1511-1521. 被引量:1
  • 7Reimers A, Sjursen W, Helde G, et al. Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine[J]. Eur J Drug Metab Pharmacokinet, 2014, [Epub ahead of print]. 被引量:1
  • 8Bosma P J, Goldhoorn B, Oude-Elferink R P, et al. A mutation in bilirubin uridine 5′-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II[J]. Gastroenterology, 1993, 105(1): 216-220. 被引量:1
  • 9Bhutani V K, Gourley G R, Adler S, et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia[J]. Pediatrics, 2000, 106(2): E17. 被引量:1
  • 10Xing Y, Yang L, Wang L, et al. Systematic screening for polymorphisms within the UGT1A6 gene in three Chinese populations and function prediction through structural modeling[J]. Pharmacogenomics, 2009, 10(5): 741-752. 被引量:1

二级参考文献10

  • 1Hsieh S Y,Wu Y H,Lin D Y,et al. Correlation of mutational analysis to clinical features in Taiwan Residents patients with Gilbert’s syndrome[J]. Am J Gastroenterol,2001,96(4):1188-1193. 被引量:1
  • 2Takeuchi K,Kobayashi Y,Tamaki S,et al. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects[J]. J Gastroenterol Hepatol,2004,19(9):1023-1028. 被引量:1
  • 3Ritter J K,Chen F,Sheen Y Y,et al. A novel complex locus UGT1 encodes human bilirubin,phenol,and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini[J]. J Biol Chem,1992,267(5):3257-3261. 被引量:1
  • 4Dabke P S,Colah R B,Ghosh K K,et al. Role of co-inherited Gilbert syndrome on hyperbilirubinemia in Indian beta thalassemia patients[J]. Hematology,2014,19(7):388-392. 被引量:1
  • 5Rawa K,Adamowicz-Salach A,Matysiak M,et al. Coexistence of Gilbert syndrome with hereditary haemolytic anaemias[J]. J Clin Pathol,2012,65(7):663-665. 被引量:1
  • 6Zahedpasha Y,Ahmadpour M,Niaki H A,et al. Relation between Neonatal Icter and Gilbert Syndrome in Gloucose-6-Phosphate Dehydrogenase Deficient Subjects[J]. J Clin Diagn Res,2014,8(3):63-65. 被引量:1
  • 7Owens I S,Ritter J K. The novel bilirubin/phenol UDP-glucuronosyltransferase UGT1 gene locus:implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes[J]. Pharmacogenetics,1992,2(3):93-108. 被引量:1
  • 8Bosma P J,Chowdhury J R,Bakker C,et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome[J]. N Engl J Med,1995,333(18):1171-1175. 被引量:1
  • 9Hunt S C,Kronenberg F,Eckfeldt J H,et al. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait:the NHLBI family heart study[J]. Atherosclerosis,2001,154(3):747-754. 被引量:1
  • 10Bock K W. Homeostatic control of xeno-and endobiotics in the drug-metabolizing enzyme system[J]. Biochem Pharmacol,2014,90(1):1-6. 被引量:1

共引文献2

同被引文献10

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部